Literature DB >> 21402297

Development of a conceptual framework and calibrated item banks to measure patient-reported dyspnea severity and related functional limitations.

Seung W Choi1, David E Victorson, Susan Yount, Susan Anton, David Cella.   

Abstract

OBJECTIVES: Chronic obstructive pulmonary disease is a major global health problem. Although several patient-reported outcome (PRO) measures of chronic obstructive pulmonary disease exist, none were developed using patient-driven concept development. We developed an item bank for dyspnea severity and related functional limitations on the basis of a PRO conceptual framework derived from patient input.
METHODS: We identified a large pool of existing items based on a conceptual framework and literature review. Using patient and expert review panels and an item refinement/modification process, we developed an item bank aligned with the conceptual framework, which subsequently underwent psychometric testing via an online Internet panel of dyspnea patients (N = 608).
RESULTS: Exploratory factor analysis suggested a dominant first factor accounting for about 78% of the total variance. Confirmatory factor analysis supported a unidimensional model. Item response theory analysis demonstrated good model fit, and differential item functioning analyses indicated that the 33-item scale showed potential for measurement equivalence across sex. A 10-item short form produced comparable scores (r = 0.98) and a computerized adaptive-testing simulation indicated efficient measurement with fewer items (mean 4.65 items).
CONCLUSIONS: An efficient patient-reported measure of dyspnea severity and related functional limitations, based on a patient-driven PRO conceptual framework, is now available for further validation and use.
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21402297     DOI: 10.1016/j.jval.2010.06.001

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  14 in total

1.  Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis.

Authors:  Monique E Hinchcliff; Jennifer L Beaumont; Mary A Carns; Sofia Podlusky; Krishna Thavarajah; John Varga; David Cella; Rowland W Chang
Journal:  J Rheumatol       Date:  2014-11-01       Impact factor: 4.666

2.  Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Susan E Yount; Jennifer L Beaumont; Shih-Yin Chen; Karen Kaiser; Katy Wortman; David L Van Brunt; Jeffrey Swigris; David Cella
Journal:  Lung       Date:  2016-02-09       Impact factor: 2.584

3.  Development and validation of a computer adaptive test for measuring dyspnea in heart failure.

Authors:  Bernice Ruo; Seung W Choi; David W Baker; Kathleen L Grady; David Cella
Journal:  J Card Fail       Date:  2010-04-08       Impact factor: 5.712

4.  Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form.

Authors:  Monique Hinchcliff; Jennifer L Beaumont; Krishna Thavarajah; John Varga; Anh Chung; Sofia Podlusky; Mary Carns; Rowland W Chang; David Cella
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

5.  A comparison of computer adaptive tests (CATs) and short forms in terms of accuracy and number of items administrated using PROMIS profile.

Authors:  Eisuke Segawa; Benjamin Schalet; David Cella
Journal:  Qual Life Res       Date:  2019-10-08       Impact factor: 4.147

6.  Qualitative research with patients and caregivers of patients with PIK3CA related overgrowth spectrum: content validity of clinical outcome assessments.

Authors:  Kimberly Raymond; Susan Vallow; Cory Saucier; Kristi Jackson; Michelle K White; Andrew Lovley; Denise D'Alessio
Journal:  J Patient Rep Outcomes       Date:  2022-07-13

7.  Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease.

Authors:  Anne C Melzer; Laura C Feemster; Kristina Crothers; Shannon S Carson; Suzanne E Gillespie; Ashley G Henderson; Jerry A Krishnan; Peter K Lindenauer; Mary Ann McBurnie; Richard A Mularski; Edward T Naureckas; A Simon Pickard; David H Au
Journal:  Ann Am Thorac Soc       Date:  2016-09

Review 8.  Scale development: ten main limitations and recommendations to improve future research practices.

Authors:  Fabiane F R Morgado; Juliana F F Meireles; Clara M Neves; Ana C S Amaral; Maria E C Ferreira
Journal:  Psicol Reflex Crit       Date:  2017-01-25

9.  Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form.

Authors:  Fang-Ju Lin; A Simon Pickard; Jerry A Krishnan; Min J Joo; David H Au; Shannon S Carson; Suzanne Gillespie; Ashley G Henderson; Peter K Lindenauer; Mary Ann McBurnie; Richard A Mularski; Edward T Naureckas; William M Vollmer; Todd A Lee
Journal:  BMC Med Res Methodol       Date:  2014-06-16       Impact factor: 4.615

10.  Responsiveness of PROMIS® to change in chronic obstructive pulmonary disease.

Authors:  Susan E Yount; Charles Atwood; James Donohue; Ron D Hays; Debra Irwin; Nancy Kline Leidy; Honghu Liu; Karen L Spritzer; Darren A DeWalt
Journal:  J Patient Rep Outcomes       Date:  2019-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.